This suggests that the cognitive impairment of AD mice may be related to the insulin signaling pathway, and DSS intervention may reduce the accumulation of neuropathological products by regulating the IRS1/GSK3β/Wnt‐β‐catenin pathway, thus playing a cognitive protective role. This evidence concerns the gene GSK3B and Alzheimer disease.